American International Group, Inc. Biocryst Pharmaceuticals Inc Transaction History

American International Group, Inc.

  • $8.5 Billion
  • Q3 2024

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
SELL
$4.89 - $7.65 $3,921 - $6,135
-802 Reduced 0.85%
93,415 $474,000
Q4 2023

Feb 13, 2024
SELL
$4.98 - $6.77 $1,897 - $2,579
-381 Reduced 0.4%
94,217 $564,000
Q3 2023

Nov 13, 2023
BUY
$6.71 - $7.92 $22,572 - $26,642
3,364 Added 3.69%
94,598 $669,000
Q2 2023

Aug 04, 2023
BUY
$6.96 - $8.81 $11,915 - $15,082
1,712 Added 1.91%
91,234 $642,000
Q1 2023

May 12, 2023
BUY
$7.94 - $11.84 $14,149 - $21,098
1,782 Added 2.03%
89,522 $746,000
Q4 2022

Feb 10, 2023
SELL
$10.5 - $14.2 $3,360 - $4,544
-320 Reduced 0.36%
87,740 $1.01 Million
Q3 2022

Nov 14, 2022
BUY
$10.79 - $14.81 $13,422 - $18,423
1,244 Added 1.43%
88,060 $1.11 Million
Q2 2022

Aug 12, 2022
SELL
$7.89 - $17.88 $20,277 - $45,951
-2,570 Reduced 2.88%
86,816 $919,000
Q1 2022

May 13, 2022
SELL
$11.56 - $19.76 $72,735 - $124,329
-6,292 Reduced 6.58%
89,386 $1.45 Million
Q4 2021

Feb 11, 2022
SELL
$11.18 - $15.46 $18,301 - $25,308
-1,637 Reduced 1.68%
95,678 $1.33 Million
Q3 2021

Nov 12, 2021
SELL
$14.21 - $17.65 $32,853 - $40,806
-2,312 Reduced 2.32%
97,315 $1.4 Million
Q2 2021

Aug 13, 2021
SELL
$9.5 - $17.24 $31,587 - $57,322
-3,325 Reduced 3.23%
99,627 $1.58 Million
Q1 2021

May 07, 2021
BUY
$7.37 - $13.61 $2,004 - $3,701
272 Added 0.26%
102,952 $1.05 Million
Q4 2020

Feb 12, 2021
SELL
$3.37 - $8.61 $9,928 - $25,365
-2,946 Reduced 2.79%
102,680 $765,000
Q3 2020

Nov 04, 2020
BUY
$3.43 - $5.53 $38,714 - $62,417
11,287 Added 11.96%
105,626 $363,000
Q2 2020

Aug 12, 2020
BUY
$1.9 - $5.61 $6,270 - $18,513
3,300 Added 3.62%
94,339 $450,000
Q1 2020

May 04, 2020
SELL
$1.6 - $4.11 $2,724 - $6,999
-1,703 Reduced 1.84%
91,039 $182,000
Q4 2019

Feb 05, 2020
BUY
$1.59 - $3.45 $36,900 - $80,067
23,208 Added 33.38%
92,742 $320,000
Q3 2019

Nov 08, 2019
SELL
$2.5 - $3.73 $1,210 - $1,805
-484 Reduced 0.69%
69,534 $199,000
Q2 2019

Aug 13, 2019
BUY
$2.91 - $9.15 $1,268 - $3,989
436 Added 0.63%
70,018 $265,000
Q1 2019

May 06, 2019
SELL
$7.38 - $9.72 $16,634 - $21,908
-2,254 Reduced 3.14%
69,582 $566,000
Q4 2018

Feb 13, 2019
SELL
$6.51 - $9.6 $3,606 - $5,318
-554 Reduced 0.77%
71,836 $580,000
Q3 2018

Nov 09, 2018
BUY
$5.52 - $7.99 $45,462 - $65,805
8,236 Added 12.84%
72,390 $552,000
Q2 2018

Aug 08, 2018
BUY
$4.6 - $6.52 $6,991 - $9,910
1,520 Added 2.43%
64,154 $368,000
Q1 2018

May 07, 2018
SELL
$4.35 - $5.82 $14,650 - $19,601
-3,368 Reduced 5.1%
62,634 $299,000
Q4 2017

Feb 09, 2018
BUY
$4.16 - $5.33 $51,238 - $65,649
12,317 Added 22.94%
66,002 $324,000
Q3 2017

Nov 09, 2017
BUY
$4.1 - $5.97 $220,108 - $320,499
53,685
53,685 $281,000

Others Institutions Holding BCRX

# of Institutions
278
Shares Held
172M
Call Options Held
625K
Put Options Held
739K
View Full List

About BIOCRYST PHARMACEUTICALS INC

BCRX Quotes by TradingView
  • Ticker BCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,944,992
  • Market Cap $1.45B
  • Description
  • BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...
More about BCRX
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email